BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Definiens AG Expands Large Data Analytics Functionality to Accelerate Image-based Research and Development


6/21/2012 10:46:48 AM

Munich, Germany, June 21, 2012 / B3C newswire / - Definiens®, the leading provider of image analysis and data mining solutions for quantitative digital pathology, today announced the release of Definiens Image Miner™ 2. The new product provides researchers in the life sciences with deeper insights into underlying biology by integrating image with data analysis. Image Miner 2 makes the wealth of information in biomedical images accessible, accelerating life sciences research and allowing for successful biomarker development.

By supporting highly effective data exploration and study results, the duration of image-based studies can be reduced from weeks to days. Definiens Image Miner 2 provides researchers with the unique ability to easily switch between investigating trends and patterns in large data sets and drawing attention to subtle analysis details in single images. Using the statistic toolbox and the comprehensive visualization options, insights and new knowledge can be generated from images in an unprecedented way. In combination with Definiens image analysis solutions, Image Miner facilitates the processing of even very large data sets.

“For the first time in this industry workflows are available that allow researchers to unlock the information and knowledge residing in images in a highly productive manner.” says Thomas Heydler, CEO of Definiens. “Biomedical images are a vast, often untapped source of information and represent big data at the same time. Up to this point they often have not been available for detailed analysis. By turning images into computational information, Definiens supports researchers in their endeavors to efficiently develop novel biomarkers, drugs and diagnostics.”

With seamless links between readouts and underlying images, related target structures are only a mouse-click away from relevant data points. Image Miner 2 supports predictive modeling by correlating image analysis results with data from other sources, such as patient outcome data in the development of predictive biomarkers. Interactive plots and data tables provide real-time feedback on study trends, while quality control and assay validation are facilitated by instant identification of outliers and artifacts.

For more information on Definiens Image Miner 2, sign up for the introductory launch webinar, and find examples illustrating how Definiens Image Miner 2 supports tissue-based biomarker development or high content screening, respectively.

About Definiens

Definiens is the leading provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived from other sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives.

Definiens is headquartered in Munich, Germany, and has offices throughout the United States.

Press Contacts

Definiens

Dr. Florian Leiss

Manager Marketing Communications

+49 (89) 231180 24

fleiss@definiens.com

Post+Beam

Steven Pludwin

646.442.2775

pludwin@postandbeam.is



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES